![](/img/cover-not-exists.png)
MP87-03 EVALUATION OF THE ERα AGONIST, GTX-758 (250 MG DAILY), IN MEN WITH METASTATIC (MCRPC) AND NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC)
Yu, Evan, Hancock, Michael, Babicz, Tamás, Aronson, William, Pápai, Zsuzsanna, Géczi, Lajos, Getzenberg, RobertVolume:
193
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2015.02.1948
Date:
April, 2015
File:
PDF, 221 KB
english, 2015